AG
REGN icon

AlTi Global’s Regeneron Pharmaceuticals REGN Stock Holding History

AlTi Global’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
1,864
+7
+0.4% +$4.76K 0.02% 248
2026
Q1 		$1.43M Buy
1,857
+1,407
+313% +$1.08M 0.03% 191
2025
Q4 		$347K Sell
450
-14
-3% -$9.51K 0.01% 358
2025
Q3 		$261K Buy
464
+49
+12% +$27.7K 0.01% 390
2025
Q2 		$218K Buy
415
+11
+3% +$6.14K 0.01% 398
2025
Q1 		$256K Sell
404
-9
-2% -$6.19K 0.01% 351
2024
Q4 		$294K Buy
413
+5
+1% +$4.2K 0.01% 342
2024
Q3 		$429K Sell
408
-119
-23% -$132K 0.01% 291
2024
Q2 		$554K Sell
527
-11
-2% -$10.7K 0.01% 248
2024
Q1 		$518K Buy
538
+103
+24% +$97.9K 0.01% 243
2023
Q4 		$382K Buy
+435
New +$358K 0.01% 267

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

AlTi Global's REGN Position: Q2 2026 in Review

AlTi Global increased its Regeneron Pharmaceuticals (REGN) stake by 0.38% in Q2 2026, buying an estimated $4.76K and bringing the position to 1,864 shares worth $1.16M. The position accounts for 0.02% of the portfolio, ranked #248.

AlTi Global first reported a position in REGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.43M in Q1 2026. 729 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • AlTi Global held 1,864 shares of Regeneron Pharmaceuticals worth $1.16M as of Q2 2026.
  • AlTi Global bought 7 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $4.76K.
  • Regeneron Pharmaceuticals made up 0.02% of AlTi Global's portfolio in Q2 2026, its #248 holding.
  • AlTi Global first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • AlTi Global's Regeneron Pharmaceuticals position peaked at $1.43M in Q1 2026.
  • 729 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on AlTi Global's 13F filing for Q2 2026, filed 5 Aug 2026.